Prebiotics and age, but not probiotics affect the transformation of 2-amino-3-methyl-3H-imidazo[4,5-f]quinoline (IQ) by fecal microbiota - An in vitro study

Anaerobe

Volumn 39, Issue , 2016, Pages 124-135

  Nowak, Adriana ^a   Czyzowska, Agata ^a   Huben, Krzysztof ^a   Sójka, Michał ^a   Kuberski, Sławomir ^a   Otlewska, Anna ^a   Ślizewska, Katarzyna ^a  

^a LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

7 OH IQ; Ageing; Fecal microbiota; FTIR; LC MSn; NMR; Prebiotics; Probiotics

Indexed keywords

2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; 2 AMINO 3,6 DIHYDRO 3 METHYL 7H IMIDAZO[4,5 F]QUINOLINE 7 ONE; AROMATIC AMINE; CARCINOGEN; HETEROCYCLIC AMINE; PREBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG; 2-AMINO-3,6-DIHYDRO-3-METHYL-7H-IMIDAZO(4,5-F)QUINOLINE-7-ONE; 2-AMINO-3-METHYL-3H-IMIDAZO(4,5-F)QUINOLINE; BACTERIAL DNA; IMIDAZOLE DERIVATIVE; QUINOLINE DERIVATIVE; QUINOLONE DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; BACTERIAL STRAIN; CHILD; COMET ASSAY; CONTROLLED STUDY; COOKING; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FECES MICROFLORA; HEALTH STATUS; HIGH TEMPERATURE PROCEDURES; HUMAN; IN VITRO STUDY; INFANT; INFRARED SPECTROSCOPY; INTESTINE FLORA; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEAT; NUCLEAR MAGNETIC RESONANCE; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; BIOTRANSFORMATION; CHEMISTRY; DRUG EFFECTS; FECES; FEMALE; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; NEWBORN; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOTRANSFORMATION; CARCINOGENS; CHROMATOGRAPHY, LIQUID; CLOSTRIDIUM DIFFICILE; COMET ASSAY; DNA, BACTERIAL; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FECES; FEMALE; HUMANS; IMIDAZOLES; INFANT; INFANT, NEWBORN; MALE; MASS SPECTROMETRY; MIDDLE AGED; PREBIOTICS; PROBIOTICS; QUINOLINES; QUINOLONES;

EID: 84962764640     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2016.03.009     Document Type: Article

References (47)

1. Rahman ur U., Sahar A., Khan M.I., Nadeem M. Production of heterocyclic aromatic amines in meat: chemistry, health risks and inhibition. A review. LWT Food Sci. Technol. 2014, 59:229-233.
2. Sinha R., Knize M.G., Salmon C.P., Brown E.D., Rhodes D., Felton J.S., Levander O.A., Rothman N. Heterocyclic amine content of pork products cooked by different methods and to varying degrees of doneness. Food Chem. Toxicol. 1998, 36:289-297.
3. Keating G.A., Layton D.W., Felton J. Factors determining dietary intakes of heterocyclic aromatic amines in cooked foods. Mutat. Res. 1999, 443:149-156.
4. Gibis M., Weiss J. Impact of precursors creatine, creatinine, and glucose on the formation of heterocyclic aromatic amines in grilled patties of various animals species. J. Food Sci. 2015, 80:C2430-C2439.
5. IARC Monographs on the evaluation of carcinogenic risks to human. Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins 1993, vol. 56:165-195. International Agency for Research on Cancer, Lyon.
6. Turesky R.J., Le Marchand L. Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines. Chem. Res. Toxicol. 2011, 24:1169-1214.
7. 2 -dG adduct in the NarI DNA recognition sequence. Nucleic Acids Res. 2014, 42:3450-3463.
8. Turesky R.J., Murkovic J. DNA adduct formation of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline at the C-8 and N2 atoms of guanine. Chem. Res. Toxicol. 1994, 7:752-761.
9. Krul C., Luiten-Schuite A., Baandagger R., Verhagen H., Mohn G., Feron V., Havenaar R. Application of a dynamic in vitro gastrointestinal tract model to study the availability of food mutagens, using heterocyclic aromatic amines as model compounds. Food Chem. Toxicol. 2000, 38:783-792.
10. Carman R.J., Van Tassell R.L., Kingston D.G.I., Bashir M., Wilkins T.D. Conversion of IQ, a dietary pyrolysis carcinogen to a direct - acting mutagen by normal intestinal bacteria in humans. Mutat. Res. 1988, 206:335-342.
11. Van Tassell R.I., Carman R.J., Kingston D.G.I., Wilkins T.D. Bacterial metabolism in humans of the carcinogen IQ to the direct acting mutagen hydroxyl-IQ. Microb. Ecol. Health Dis. 1989, 2:123-129.
12. Humblot C., Lhoste E., Knasmuller S., Gloux K., Bruneau A., Bensaada M., Durao J., Rabot S., Andrieux C., Kassie F. Protective effects of Brussels sprouts, oligosaccharides and fermented milk towards 2-amino-3-methyl-3H-imidazo[4,5-f]quinolone-induced genotoxicity in the human flora associated F344 rat: role of xenobiotic metabolising enzymes and intestinal microflora. J. Chromatogr. B 2004, 802:231-327.
13. Rumney C.J., Rowland I.R., O'Neill I.K. Conversion of IQ to 7-OHIQ by gut microflora. Nutr. Cancer 1993, 19:67-76.
14. Hill C., Guarner F., Reid G., Gibson G.R., Marenstein D.J., Pot B., Morelli L., Canani R.B., Flint J., Salminen S., Calder P.C., Sanders M.E. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014, 11:506-514.
15. Duncan S.H., Flint H.J. Probiotics and prebiotics and health in ageing populations. Maturitas 2013, 75:44-50.
16. Burns A.J., Rowland I.R. Anti - carcinogenicity of probiotics and prebiotics. Curr. Issues Intest. Microbiol. 2000, 1:13-24.
17. Sunkata R., Herring J., Walker L.T., Verghese M. Chemopreventive potential of probiotics and prebiotics. Food Nutr. Sci. 2014, 5:1800-1809.
18. Bax A., Davis D.G. MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 1985, 65:355-360.
19. Liu M., Mao X., He C., Huang H., Nicholson J.K., Lindon J.C. Improved watergate pulse sequences for solvent suppression in NMR spectroscopy. J. Magn. Reson. 1998, 132:125-129.
20. Zhang Z., Schwartz S., Wagner L., Miller W. A greedy algorithm for aligning DNA sequences. J. Comput. Biol. 2010, 7:203-214.
21. Cukrowska B., Motyl I., Kozakova H., Schwarzer M., Górecki R.K., Klewicka E., Ślizewska K., Libudzisz Z. Probiotic Lactobacillus strains: in vitro and in vivo studies. Folia Microbiol. 2009, 54(6):533-537.
22. Nowak A., Ślizewska K., Klewicka E. Effect of probiotic lactobacilli on faecal enzyme and genotoxic activity in human faecal water in the presence of the carcinogen PhIP in vitro. Int. J. Dairy Technol. 2012, 65(2):300-307.
23. Nowak A., Ślizewska K. β-Glucuronidase and β-glucosidase activity and human fecal water genotoxicity in the presence of probiotic lactobacilli and the heterocyclic aromatic amine IQ in vitro. Environ. Toxicol. Pharmacol. 2014, 37:66-73.
24. Nowak A., Ślizewska K., Błasiak J., Libudzisz Z. Lactobacillus casei DN 114 001 reduces the activity of faecal enzymes and genotoxicity of faecal water in the presence of heterocyclic aromatic amines. Anaerobe 2014, 30:129-136.
25. Jochym K., Kapuśniak J., Barczyńska R., Ślizewska K. New starch preparations resistant to enzymatic digestion. J. Sci. Food Agric. 2012, 92:886-891.
26. Błasiak J., Kowalik J. A comparison of the in vitro genotoxicity of tri- and hexavalent chromium. Mutat. Res. 2000, 469:135-145.
27. Humblot C., Combourieu B., Väisänen M.L., Furet J.P., Delort A.M., Rabot S. 1H nuclear magnetic resonance spectroscopy-based studies of the metabolism of food-borne carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline by human intestinal microbiota. Appl. Environ. Microbiol. 2005, 71:5116-5123.
28. Bashir M., Kingston D., Carman J.R., van Tassell R.L., Wilkins T.D. Biological formation and chemical synthesis of 2-amino-3,6-dihydro-3-methyl-7H-imidazo[4,5-f]quinoline-7-one, the major metabolite of dietary carcinogen IQ by normal intestinal bacteria. Heterocycle 1987, 26:2877-2886.
29. Felton J.S., Knize M.G., Wu R.W., Colvin M.E., Hatch F.T., Malfatti M.A. Mutagenic potency of food-derived heterocyclic amines. Mutat. Res. 2007, 616:90-94.
30. Hirayama K., Baranczewski P., Akerlund J.E., Midtved T., Möller L., Rafter J. Effects of human intestinal microflora on mutagenicity of DNA adduct formation from food and environmental mutagens. Carcinogenesis 2000, 21:2105-2111.
31. Kassie F., Lhoste E.F., Bruneau A., Zsivkovits M., Ferk F., Uhl M., Zidek T., Knasmuller S. Effect of intestinal microflora from vegetarians and meat eaters on the genotoxicity of 2-amino-3-methylimidazo[4,5-f]quinoline, a carcinogenic heterocyclic amine. J. Chromatogr. B 2004, 802:211-215.
32. Humblot C., Murkovic M., Rigottier-Gois L., Bensaada M., Bouclet A., Andrieux C., Anba J., Rabot S. β-Glucuronidase in human intestinal microbiota is necessary for the colonic genotoxicity of the food-borne carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline in rats. Carcinogenesis 2007, 28:2419-2425.
33. Vanhaecke L., Van Hoof N., Van Brabandt W., Soenen B., Heyerick A., De Kimpe N., De Keukeleire D., Verstraete W., Van de Wiele T. Metabolism of the food associated carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human intestinal microbiota. J. Agric. Food Chem. 2006, 54:3454-3461.
34. Voreades N., Kozil A., Weir T.L. Diet and the development of the human intestinal microbiome. Front. Microbiol. 2014, 5:494.
35. Tiihonen K., Ouwehand A.C., Rautonen N. Human intestinal microbiota and healthy ageing. Ageing Res. Rev. 2010, 9:107-116.
36. Biagi E., Nylund L., Candela M., Ostan R., Bucci L., Pini E., Nikkila J., Monti D., Satokari R., Franceschi C., Brigidi P., De Vos W. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 2010, 5(5):e10667.
37. Saffrey M.J. Aging of the mammalian gastrointestinal tract: a complex organ system. Age 2014, 36:1019-1032.
38. Zapata H.J., Quagliarello V.J. The microbiota and microbiome in aging: potential implications in health and age-related diseases. J. Am. Geriatr. Soc. 2015, 63:776-781.
39. Biagi E., Candela M., Fairweather S., Franceschi C., Brigidi P. Ageing of the human metaorganism: the microbial counterpart. Age 2012, 34:247-267.
40. Rondanelli M., Giacosa A., Faliva M.A., Perna S., Allieri F., Castellazzi A.M. Review on microbiota and effectiveness of probiotics use in older. World J. Clin. Cases 2015, 3:156-162.
41. Cleasson M.J., Cusak S., O'Sullivan O., Greene-Diniz R., de Weerd H., Flannery E., Marchesi J.E., et al. Composition, variability and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(1S):4586-4591.
42. Mueller S., Saunier K., Hanisch C., Norin E., Alm L., Midtvedt T., Cresci A., Silvi S., Orpianesi C., Verdenelli M.C., Clavel T., Koebnick C., Zunft H.J., Doré J., Blaut M. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl. Environ. Microbiol. 2006, 72:1027-1033.
43. Yatsunenko T., Rey F.E., Manary M.J., Trehan I., Dominguez-Bello M.G., Contreras M., Magris M., Hidalgo G., Baldassano R.N., Anokhin A.P., Heath A.C., Warner B., Reeder J., Kuczynski J., Caporaso J.G., Lozupone C.A., Lauber C., Clemente J.C., Knights D., Knight R., Gordon J.I. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
44. Vanhaecke L., Vercruysse F., Boon N., Verstraete W., Cleenwerck I., De Wachter M., De Vos P., van de Wiele T. Isolation and characterization of human intestinal bacteria capable of transforming the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Appl. Environ. Microbiol. 2008, 74:1469-1477.
45. Turbic A., Abokas J.T., Haskard C.A. Selective in vitro binding of dietary mutagens, individually or in combination, by lactic acid bacteria. Food Addit. Contam. 2002, 19:144-152.
46. Conlon M.A., Bird A.R. The impact of diet and lifestyle on gut microbiota and human health. Nutrients 2015, 7:17-44.
47. Vanhaecke L., Verstraete W., Van de Wiele T. Chemopreventive effects from prebiotic inulin towards microbial 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine bioactivation. J. Appl. Microbiol. 2009, 106:474-485.